CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $247.88M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 8.78: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
17.78%
Annual Rate
USD 0.60Paid annual
Payout Ratio
0.0%Sustainable
Paying Dividends
5 yr
Payback Period
5.6 yr
Last Ex-Dividend
Apr 7, 2026
Last Payment
Apr 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
247.88MUSDvs all stocks (USD)
Revenue (TTM)
53.66MUSDvs all stocks (USD)
Profit Margin
-5.19%Beta
0.8870xvs all stocks
52-Week Change
-62.33%vs all stocks
Market Capitalization
247.88MUSDvs all stocks (USD)
Enterprise Value
130.74MUSDvs all stocks (USD)
Forward P/E
3.19xPrice to Sales (TTM)
4.62xPrice to Book (MRQ)
1.50xEnterprise to Revenue
2.44xEnterprise to EBITDA
-12.39xGross Margin
57.17%Profit Margin
-5.19%Operating Margin
33.91%Return on Assets (TTM)
-3.39%Return on Equity (TTM)
-1.49%Revenue (TTM)
53.66MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.7490USDUpdated Sep 28, 2026Quarterly Revenue Growth
-49.50%Gross Profit (TTM)
8.73MUSDvs all stocks (USD)
EBITDA (TTM)
24.26MUSDvs all stocks (USD)
Net Income (TTM)
-2.79MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-64.90%Operating Cash Flow (TTM)
-20.17MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-23.99MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.6000USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
17.78%vs all stocks
Payout Ratio
0.00%Revenue
94.57MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
49.66MUSDFY2025 · Dec 31, 2025Gross Profit
44.91MUSDFY2025 · Dec 31, 2025Operating Income
23.70MUSDvs all stocks (USD)
Pre-tax Income
30.38MUSDFY2025 · Dec 31, 2025Income Tax Expense
7.10MUSDFY2025 · Dec 31, 2025Net Income
23.28MUSDFY2025 · Dec 31, 2025EBIT
23.70MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
24.26MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
21.21MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.3300USDFY2025 · Dec 31, 2025EPS (Diluted)
0.3200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
71.53MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
71.53MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
23.28MUSDFY2025 · Dec 31, 2025Operating Cash Flow
50.34MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
154.97MUSDFY2025 · Dec 31, 2025Income Tax Paid
8.20MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
23.28MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
562.61KUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
6.43MUSDFY2025 · Dec 31, 2025Stock-based Compensation
3.68MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-90.80KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
17.90MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-578.64KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-846.31KUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Common Dividends Paid
-43.12MUSDFY2025 · Dec 31, 2025Other Financing Charges
-433.76KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-43.55MUSDFY2025 · Dec 31, 2025Shares Outstanding
71.84MSharesUpdated Sep 28, 2026Float Shares
41.13MSharesUpdated Sep 28, 2026Shares Short
3.73MSharesUpdated Sep 28, 2026Short Ratio
5.20daysvs all stocks
Short % of Shares Outstanding
8.02%vs all stocks
% Held by Insiders
42.73%vs all stocks
% Held by Institutions
50.44%vs all stocks
Total Cash (MRQ)
117.58MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.64USDUpdated Sep 28, 2026Total Debt (MRQ)
439.40KUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0027xCurrent Ratio (MRQ)
21.72xBook Value per Share (MRQ)
2.30USDUpdated Sep 28, 2026Total Assets
219.47MUSDvs all stocks (USD)
Total Current Assets
212.86MUSDFY2025 · Dec 31, 2025Total Liabilities
20.65MUSDFY2025 · Dec 31, 2025Total Non-current Assets
6.61MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.65MUSDFY2025 · Dec 31, 2025Total Current Liabilities
17.99MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
154.97MUSDFY2025 · Dec 31, 2025Accounts Receivable
3.26MUSDFY2025 · Dec 31, 2025Inventory
49.05MUSDFY2025 · Dec 31, 2025Accounts Payable
824.52KUSDFY2025 · Dec 31, 2025Short-term Debt
595.17KUSDFY2025 · Dec 31, 2025Deferred Revenue
10.24MUSDFY2025 · Dec 31, 2025Other Current Liabilities
696.11KUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.65MUSDFY2025 · Dec 31, 2025Common Stock (Book)
7.16KUSDFY2025 · Dec 31, 2025Retained Earnings
-43.07MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
198.82MUSDvs all stocks (USD)
52-Week Low
2.83USDUpdated Sep 28, 202652-Week High
9.29USDUpdated Sep 28, 202652-Week Change
-62.33%vs all stocks
Beta
0.8870xvs all stocks
50-Day MA
3.14USDUpdated Sep 28, 2026200-Day MA
4.78USDUpdated Sep 28, 2026Avg 10-Day Volume
695.35KSharesUpdated Sep 28, 2026Avg 30-Day Volume
719.63KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.0400USDUpdated Sep 28, 2026Other Income / Expense
6.68MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.57Profit Margin: -0.05
Financial Health
Altman Z-Score 8.78: safe zoneNotable
Altman Z-Score: 8.78
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $247.88M, lower than 95% of all stocks globallySignificant
Market cap (USD): 247,881,520Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Akebia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
Acimmune SA
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Daito Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Palisade Bio Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seikagaku Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationClose Below 40W SMA With Profitability
Sportradar Group AG
1 interpretationClose Below 40W SMA With Profitability
Shanghai Taisheng Wind Power Equipment Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability